Edition:
United States

Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

25.17USD
24 Feb 2017
Change (% chg)

$-0.03 (-0.12%)
Prev Close
$25.20
Open
$24.94
Day's High
$25.23
Day's Low
$24.71
Volume
137,059
Avg. Vol
393,318
52-wk High
$41.69
52-wk Low
$22.67

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.52 December 27 Feb 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 5 5 5 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.70 1.70 1.70 1.70

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 6 4.12 8.59 2.00 --
Quarter Ending Jun-17 6 4.14 8.59 2.00 --
Year Ending Dec-17 9 35.89 151.80 9.00 86.59
Earnings (per share)
Quarter Ending Mar-17 6 -0.52 -0.38 -0.60 --
Quarter Ending Jun-17 6 -0.55 -0.39 -0.66 --
Year Ending Dec-17 10 -1.86 0.80 -2.83 -0.69

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 4.07 3.01 1.07 26.22
Quarter Ending Jun-16 3.77 3.19 0.58 15.34
Quarter Ending Mar-16 9.49 18.20 8.71 91.77
Quarter Ending Dec-15 15.69 3.80 11.89 75.76
Quarter Ending Sep-15 4.38 4.16 0.22 5.13
Earnings (per share)
Quarter Ending Sep-16 -0.53 -0.55 0.02 -3.02
Quarter Ending Jun-16 -0.50 -0.59 0.09 -17.95
Quarter Ending Mar-16 -0.26 0.13 0.39 -150.13
Quarter Ending Dec-15 -0.09 -0.81 0.72 -779.48
Quarter Ending Sep-15 -0.46 -0.36 0.10 -21.50

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 4.12 4.12 4.12 3.54 --
Quarter Ending Jun-17 4.14 4.14 4.14 3.56 --
Year Ending Dec-17 35.89 35.89 35.89 35.89 86.59
Earnings (per share)
Quarter Ending Mar-17 -0.52 -0.52 -0.53 -0.55 --
Quarter Ending Jun-17 -0.55 -0.55 -0.55 -0.56 --
Year Ending Dec-17 -1.86 -1.86 -1.86 -1.86 -0.69

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 0 0
Quarter Ending Jun-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Mar-17 0 0 1 0
Quarter Ending Jun-17 0 0 1 0
Year Ending Dec-17 0 0 1 0

More From Around the Web